2024年の記事一覧

• Igase M, Igase K, Hino S, Uchida D, Okada Y, Ochi M, Tabara Y, Ohyagi Y.
  Association of periodontitis with mild cognitive impairment in older adults.
  JAR Life 2024; 13:108-112.

• Fujishita S, Inoue A, Watanabe H, Nichikawa M, Taniwaki M, Matsumoto S, Ochi M, Suemori K, Watanabe A, Kitazawa R, Shigekawa S, Ohyagi Y, Kunieda T.
  A case of immunocompetent intracranial cryptococcoma in which intraoperative rapid pathological diagnosis and polymerase chain reaction led to early treatment: What to know to avoid misdiagnosis as brain tumor.
  Surg Neurol Int 2024; 15:330

• Morikawa T, Miura S, Uchiyama Y, Hiruki S, Sun Y, Fujioka R, Shibata H.
  Hexanucleotide repeat expansion in SCA36 reduces the expression of genes involved in ribosome biosynthesis and protein translation.
  J Hum Genet 2024; 69:411-416.

• Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H, Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T, Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C, Watanabe M, Fujihara K.
  Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan.
  Mult Scler Relat Disord 2024; 90:105829

• Watanabe M, Isobe N, Niino M, Nakashima I, Matsushita T, Sakai Y, Nakahara J, Kawachi I, Ochi H, Nakatsuji Y, Nakamura Y, Nakamura K, Sakata K, Matsui M, Kuwabara S, Kira JI
  Research Committee of Neuroimmunological Diseases in Japan. Prevalence of, and disability due to, multiple sclerosis and neuromyelitis optica spectrum disorder in Japan by the fifth nationwide survey.
  Neurology 2024; 103:e209992

• Takei S, Ochi M, Shiraoka A, Matsumoto S, Fujishita S, Okada Y, Miura S, Ochi H, Igase M, Ohyagi Y.
  Frailty and aging are associated with cognitive decline and dermal advanced glycation end-product accumulation in older Japanese men.
  Arch Gerontol Geriatr Plus 2024; 1:100071

• Stefanucci L, Moslemi C, Tomé AR, Virtue S, Bidault G, Gleadall NS, Watson LPE, Kwa JE, Burden F, Farrow S; DBDS Genetic Consortium; Chen J; MAGIC (including Igase M, Ohyagi Y); Võsa U, Burling K, Walker L, Ord J, Barker P, Warner J, Frary A, Renhstrom K, Ashford SE, Piper J, Biggs G, Erber WN, Hoffman GJ, Schoenmakers N, Erikstrup C, Rieneck K, Dziegiel MH, Ullum H, Azzu V, Vacca M, Aparicio HJ, Hui Q, Cho K, Sun YV, Wilson PW, Bayraktar OA, Vidal-Puig A, Ostrowski SR, Astle WJ, Olsson ML, Storry JR, Pedersen OB, Ouwehand WH, Chatterjee K, Vuckovic D, Frontini M.
  SMIM1 absence is associated with reduced energy expenditure and excess weight.
  Med 2024; 5:1083-1095.

• Suzuki K, Hatzikotoulas K, Southam L, Taylor HJ, Yin X, Lorenz KM, Mandla R, Huerta-Chagoya A, Melloni GEM, Kanoni S, Rayner NW, Bocher O, Arruda AL, Sonehara K, Namba S, Lee SSK, Preuss MH, Petty LE, Schroeder P, Vanderwerff B, Kals M, Bragg F, Lin K, Guo X, Zhang W, Yao J, Kim YJ, Graff M, Takeuchi F, Nano J, Lamri A, Nakatochi M, Moon S, Scott RA, Cook JP, Lee JJ, Pan I, Taliun D, Parra EJ, Chai JF, Bielak LF, Tabara Y, et al. (including Igase M)
  Genetic drivers of heterogeneity in type 2 diabetes pathophysiology.
  Nature 2024; 627:347-357.

• Tabara Y, Okada Y, Ochi M, Ohyagi Y, Igase M.
  One-leg standing time is a simple measure for loss of skeletal muscle mass and fat deposition in muscle: the J-SHIPP study.
  Aging Clin Exp Res 2024; 36:7

• Miura S, Watanabe E, Senzaki K, Hiruki S, Matsumoto S, Morikawa T, Uchiyama Y, Kurata S, Ochi M, Ohyagi Y, Shibata H.
  Episodic ataxia type 2 with a novel missense variant (Leu602Arg) in CACNA1A.
  Hum Genome Var 2024; 11:3

• Okabe H, Ochi M, Matsumoto S, Ohyagi Y.
  Primary intramedullary lymphoma with a long spinal cord lesion.
  Int Med 2024; 63:1519-1520.

• 三浦史郎．
  ケースレポートQUIZ「20歳男性，ふらつく」.
  NEURO LOGICA 2024; 5:13-14.